Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPROVE: MRI Techniques for Esophageal Cancer Stratification
NCT02253602Completed
- Sponsor
- University of Amsterdam
- Start
- Sep 2014
- Primary completion
- May 2018
- Modality
- Antibody Fragments, Polymer-based Nanoparticles
- Countries
- 1
01
Overview
Open-label trial of dapirolizumab pegol in esophageal cancer, sponsored by University of Amsterdam. Started Sep 2014; status: completed.
02
Drugs
dapirolizumab pegol
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT02253602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02253602.